Gsk Plc · LSE:GSK

Gsk — GlaxoSmithKline Consumer Healthcare — Q1 FY2019-20 Earnings Presentation

5 slides from Gsk's earnings presentation, Oct 22, 2019

Slide 1: GlaxoSmithKline Consumer Healthcare Limited Financial Results Q1 FY19-20
GlaxoSmithKline Consumer Healthcare Limited Financial Results Q1 FY19-20
Slide 2: Quarter Highlights
Quarter Highlights Revenue increased by 8% (Volume Growth 5.4%) PBT increased by 24% • Continued investment behind brands: 13% vs LY to fund innovation & drive Horlicks Campaign Drive HFD Consumption • Brand building initiatives, continue to strengthen / expand the initiatives: • A 360-degree market
Slide 3: Financial Performance: Q1 FY19-20
Financial Performance: Q1 FY19-20 Particulars Q1 19-20 Q1 18-19 Growth % Revenue from Operations 1,194 1,107 8% EBITDA 332 267 24% PBT 386 312 24% Net Sales Q1 FY 19-20 7% 3% 7% 7% 42% 41% 93% Domestic Exports North South East West Exports
Slide 4: Market Share
Market Share Brand Volume Value Horlicks 50.9% Horlicks 44.3% Boost 14.9 % Boost 11.2 % Horlicks continues to be at first position in HFD category Source – AC Nielsen; Market Share L3M June 19
Slide 5: Thank You
Thank You